Mobia Medical (NASDAQ:MOBI) Rating Increased to Hold at Zacks Research

Mobia Medical (NASDAQ:MOBI) was upgraded by stock analysts at Zacks Research to a “hold” rating in a report released on Wednesday,Zacks.com reports.

MOBI has been the topic of a number of other reports. JPMorgan Chase & Co. started coverage on Mobia Medical in a report on Tuesday. They set an “overweight” rating and a $15.00 price objective on the stock. BTIG Research started coverage on Mobia Medical in a report on Tuesday. They set a “buy” rating and a $19.00 price objective on the stock. The Goldman Sachs Group started coverage on Mobia Medical in a report on Tuesday. They set a “buy” rating and a $31.00 price objective on the stock. Wall Street Zen raised Mobia Medical to a “hold” rating in a report on Saturday, May 16th. Finally, Wolfe Research started coverage on Mobia Medical in a report on Tuesday. They set an “outperform” rating on the stock. Five analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $20.25.

Mobia Medical Stock Performance

NASDAQ:MOBI opened at $13.84 on Wednesday. Mobia Medical has a twelve month low of $10.19 and a twelve month high of $14.77. The stock has a market capitalization of $457.90 million, a price-to-earnings ratio of 66.00 and a beta of 2.84.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings results on Thursday, June 4th. The company reported $999.00 earnings per share for the quarter.

Insiders Place Their Bets

In related news, Director William T. Harrington purchased 533,333 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were acquired at an average cost of $15.00 per share, with a total value of $7,999,995.00. Following the purchase, the director directly owned 2,006,716 shares of the company’s stock, valued at approximately $30,100,740. This trade represents a 36.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Dana G. Jr. Mead purchased 7,000 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was bought at an average cost of $15.00 per share, for a total transaction of $105,000.00. Following the completion of the purchase, the director directly owned 7,000 shares in the company, valued at approximately $105,000. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders bought 1,268,332 shares of company stock worth $19,024,980.